• #835520
  • 99
  • Dr. Reddy's Laboratories #55111068852

Zoledronic Acid 5 mg / 100 mL Ready to Use Intravenous Injection Infusion Bottle 100 mL

ZOLEDRONIC ACID, SDV 5MG 100ML

Features
  • Ready-to-use formulation
  • Zoledronic acid injection is a bisphosphonate indicated for the treatment of: Hypercalcemia of malignancy, multiple myeloma and bone metastases from solid tumors
  • The zoledronic acid injection infusion time must not be less than 15 minutes given over a constant infusion rate
  • More …
Container Type
Infusion Bottle Single Use Vial
Strength
4 mg / 5 mL Concentrate 5 mg / 100 mL Ready to Use
Volume
5 mL 100 mL
  Log In to Order
or

Professionals Also Viewed


Product Specifications


McKesson #835520
Manufacturer #55111068852
ManufacturerDr. Reddy's Laboratories
Country of OriginUnknown
Alternate Manufacturer Number2017226
ApplicationBone Resorption Inhibitor
Container TypeInfusion Bottle
Dosage FormInjection
Generic Drug Code25026
Generic Drug NameZoledronic Acid
NDC Number55111-0688-52
Product DatingMcKesson Acceptable Dating: we will ship >= 90 days
Strength5 mg / 100 mL Ready to Use
TypeIntravenous
UNSPSC Code51182415
Volume100 mL
Features
  • Ready-to-use formulation
  • Zoledronic acid injection is a bisphosphonate indicated for the treatment of: Hypercalcemia of malignancy, multiple myeloma and bone metastases from solid tumors
  • The zoledronic acid injection infusion time must not be less than 15 minutes given over a constant infusion rate
  • Zoledronic acid injection must not be mixed with calcium or other divalent cation-containing infusion solutions, such as Lactated Ringer’s solution, and should be administered as a single intravenous solution in a line separate from all other drugs
  • Infusion bottle with built-in plastic hanger
  • One bottle with 100 mL solution contains 5.330 mg of zoledronic acid monohydrate, equivalent to 5 mg zoledronic acid on an anhydrous basis
  • Inactive Ingredients: 4950 mg of mannitol, USP; and 30 mg of sodium citrate, USP